Clincosm LogoSign in Get a demo

Breast Neoplasm

Showing 26 - 50 of 150
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Tumor Trial in Saint Louis (Endocare SlimLine Cryoprobe, Lumpectomy)

Not yet recruiting
  • Breast Cancer
  • Breast Neoplasm
  • Endocare SlimLine Cryoprobe
  • Lumpectomy
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 15, 2022

Breast Tumor Trial in New York (RealRisks, BNAV)

Active, not recruiting
  • Breast Neoplasm
  • RealRisks
  • BNAV
  • New York, New York
    Columbia University Medical Center
Aug 16, 2022

Breast Tumor, Metastatic Breast Cancer, Rb+ Breast Cancer Trial in Philadelphia ([18F]FLT, PET/CT, ribociclib)

Active, not recruiting
  • Breast Neoplasm
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Aug 16, 2022

Breast Tumor Trial in Grenoble Cedex 9

Completed
  • Breast Neoplasm
    • Grenoble Cedex 9, France
      Chu Grenoble Alpes
    Aug 8, 2022

    Quantitative Microvasculature Imaging for Breast Cancer

    Recruiting
    • Breast Carcinoma
    • Breast Neoplasm
    • Ultrasound
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 3, 2022

    Carcinoma, Ductal, Breast, Breast Cancer, Breast Tumor Trial in Worldwide (G1T38, Fulvestrant)

    Active, not recruiting
    • Carcinoma, Ductal, Breast
    • +2 more
    • Sofia, Bulgaria
    • +7 more
    Aug 1, 2022

    Breast Tumor, Breast Cancer, Breast Carcinoma Trial in Indianapolis (Enhanced Usual Care, Acceptance Commitment Therapy,

    Recruiting
    • Breast Neoplasm
    • +11 more
    • Enhanced Usual Care
    • +2 more
    • Indianapolis, Indiana
      Indiana University-Purdue University Indianapolis
    Jul 23, 2022

    Breast Cancer, Breast Tumor Trial in Reggio Emilia (Multidisciplinary vocational rehabilitation intervention)

    Recruiting
    • Breast Cancer
    • Breast Neoplasm
    • Multidisciplinary vocational rehabilitation intervention
    • Reggio Emilia, Italy
      Azienda Unità Sanitaria Locale Reggio Emilia
    Jul 19, 2022

    Breast Tumor Trial in Seoul (Whole breast irradiation, Whole breast and nodal irradiation)

    Active, not recruiting
    • Breast Neoplasm
    • Whole breast irradiation
    • Whole breast and nodal irradiation
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jul 10, 2022

    Breast Tumor, Primary Prevention, Risk Factors Trial in Oviedo (Web access)

    Completed
    • Breast Neoplasm
    • +3 more
    • Web access
    • Oviedo, Asturias, Spain
      Universidad de Oviedo
    Jul 11, 2022

    Estrogen Receptor Positive Breast Cancer, Breast Tumor, Metastatic Breast Cancer Trial in Philadelphia ([18F]FES)

    Active, not recruiting
    • Estrogen Receptor Positive Breast Cancer
    • +2 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania Hospital
    Jul 5, 2022

    Breast Cancer Lymphedema, Secondary Lymphedema, Iatrogenic Lymphedema Trial in Odense (Lymphovenous anastomosis)

    Recruiting
    • Breast Cancer Lymphedema
    • +21 more
    • Lymphovenous anastomosis
    • Odense, Region Of Southern Denmark, Denmark
      Department of Plastic Surgery, Odense University Hospital
    Jun 28, 2022

    Breast Tumor Trial in Rio De Janeiro (Physical exercise)

    Recruiting
    • Breast Neoplasm
    • Physical exercise
    • Rio De Janeiro, Brazil
      Instituto Nacional do Câncer / HCIII
    Jun 27, 2022

    Breast Tumor, Chemo Effect Trial in Hong Kong (Magnetic seed localization)

    Recruiting
    • Breast Neoplasm
    • Chemotherapy Effect
    • Magnetic seed localization
    • Hong Kong, Hong Kong
      University of Hong Kong
    Jun 16, 2022

    Breast Tumor, Pain Trial in Leuven (Standard physical therapy program, Modern educational program, Traditional biomedical

    Completed
    • Breast Neoplasm
    • Pain
    • Standard physical therapy program
    • +2 more
    • Leuven, Belgium
      University Hospital Leuven
    Jun 10, 2022

    Breast Tumor Trial in Granada (ATENTO-B, ATENTO-T)

    Recruiting
    • Breast Neoplasm
    • ATENTO-B
    • ATENTO-T
    • Granada, Spain
      University of Granada
    May 25, 2022

    Breast Cancer, Breast Tumor, Breast Cancer Female Trial in Houston (Paclitaxel, Carboplatin, Trastuzumab)

    Not yet recruiting
    • Breast Cancer
    • +10 more
    • Houston, Texas
    • +1 more
    May 15, 2022

    Breast Tumor Trial in United States (Eribulin Mesylate, Pembrolizumab)

    Completed
    Has Results
    • Breast Neoplasm
    • Duarte, California
    • +21 more
    Apr 6, 2022

    Breast Tumor Trial in Shanghai (Decitabine, Carboplatin)

    Terminated
    • Breast Neoplasm
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiaotong University School of Medicine
    Mar 28, 2022

    Breast Tumor Trial in China (Epirubicin plus Cyclophosphamide, Taxanes, Taxanes plus Carboplatin)

    Recruiting
    • Breast Neoplasm
    • Epirubicin plus Cyclophosphamide
    • +2 more
    • Fuding, Fujian, China
    • +26 more
    Mar 28, 2022

    Triple-Negative Breast Tumors, Breast Tumor, Breast Cancer Trial in Worldwide (Trilaciclib, Gemcitabine, Carboplatin)

    Terminated
    Has Results
    • Triple-Negative Breast Neoplasms
    • +3 more
    • Tucson, Arizona
    • +53 more
    Feb 24, 2022

    Breast Tumor, Lymphedema Trial in Antwerp, Brussel, Leuven (Information, Skin care, Compression therapy)

    Completed
    Has Results
    • Breast Neoplasm
    • Lymphedema
    • Information
    • +5 more
    • Antwerp, Belgium
    • +2 more
    Mar 8, 2022

    Breast Tumor Trial in Granada (PRESIONA)

    Recruiting
    • Breast Neoplasm
    • PRESIONA
    • Granada, Spain
      University of Granada
    Mar 8, 2022

    Breast Tumor, Breast Carcinoma, Receptor, ErbB-2 Trial in Brussels (68GaNOTA-Anti-HER2 VHH1)

    Recruiting
    • Breast Neoplasm
    • +2 more
    • 68GaNOTA-Anti-HER2 VHH1
    • Brussels, Belgium
      Uz Brussel
    Mar 4, 2022

    Breast Tumor, Chemo Effect Trial in Netherlands (trifluridine/tipiracil)

    Recruiting
    • Breast Neoplasm
    • Chemotherapy Effect
    • Arnhem, Netherlands
    • +9 more
    Mar 3, 2022